Who owns Enlivex Therapeutics Ltd?

Tip: Access positions for across all investors

Analyze quarterly positions in Enlivex Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Enlivex Therapeutics stock

Who bought or sold Enlivex Therapeutics Ltd this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Renaissance Technologies 314k $221k 99% Dec 2025
 View chart
Two Sigma Investments 195k $137k 1717% Dec 2025
 View chart
Hrt Financial 154k $108k 719% Dec 2025
 View chart
Jane Street 74k $52k 244% Dec 2025
 View chart
XTX Topco 62k $44k 45% Dec 2025
 View chart
Invesco 61k $43k 100% Dec 2025
 View chart
Citadel Advisors 61k $43k -12% Dec 2025
 View chart
Virtu Financial 47k $33k 100% Dec 2025
 View chart
UBS Group 35k $25k 766% Dec 2025
 View chart
Prosperity Consulting Group 18k $12k 0% Dec 2025
 View chart
Neuberger Berman Group 11k $7.7k 0% Dec 2025
 View chart
SkyView Investment Advisors 10k $7.0k 0% Dec 2025
 View chart
Wells Fargo & Company 9.2k $6.5k 0% Dec 2025
 View chart
Simplex Trading 8.9k $6.2k 100% Dec 2025
 View chart
Mcguire Capital Advisors 2.5k $1.8k 100% Dec 2025
 View chart
Tower Research Capital 2.2k $1.6k 100% Dec 2025
 View chart
Advisor Group Holdings 2.1k $1.5k 0% Dec 2025
 View chart
SRS Capital Advisors 1.0k $713.951000 0% Dec 2025
 View chart
Activest Wealth Management 1.0k $930.000000 0% Mar 2026
 View chart
BFSG 1.0k $704.000000 0% Dec 2025
 View chart
Steward Partners Investment Advisory 500.00 $352.000000 -80% Dec 2025
 View chart
Red Tortoise 150.00 $105.000000 0% Dec 2025
 View chart

Who sold out of Enlivex Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Citizens Financial Group Sep 2025 231k $241k
Susquehanna International Sep 2025 55k $57k
Two Sigma Securities Sep 2025 34k $36k
Sigma Investment Counselors Sep 2025 28k $29k
Group One Trading Sep 2025 7.0k $7.3k
Spire Wealth Management Sep 2025 500.00 $520.000000